Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This is the title of a recent editorial in one of the world’s leading cardiology journals, European Heart Journal, which describes the work of Ming Lei, Derek Terrar and their colleagues. The editorial refers to their article published in 2018 in Circulation that was the subject of an item in our Recent Discoveries section (https://pharm.ox.ac.uk/discoveries). The editorial points out that almost 4 million people in the world die each year from cardiac arrhythmias and that there is currently a mismatch between basic research studies and translation into drugs used in clinical practice. As Lei says ‘this has led to a loss of confidence in both existing

and potential future antiarrhythmic drugs by both clinicians and pharmaceutical companies’. Lei’s article set out to correct this mismatch and to update the famous classification of anti-arrhythmic drugs introduced 50 y ago by two former members of the Department, Vaughan-Williams and Singh. The review in Circulation was an instant ‘hit’ being in the top 5% of research outputs scored by Altimetric and has been downloaded from the journal web site nearly 15,000 times. The authors hope that the review will encourage rational clinical use of existing available anti-arrhythmic drugs in relationship to their particular mechanisms of action, thus optimizing treatment decisions, and prompting new strategies in current clinical practice. They also hope it will promote the discovery of future drugs and therapies for managing cardiac arrhythmias, so improving clinical practice. The editorial can be found at https://doi.org/10.1093/eurheartj/ehz063

Similar stories

Emptage group successful with £1m MRC-AMED award

Congratulations to the group of Professor Nigel Emptage who have been awarded an MRC-AMED grant, worth £1m, in conjuction with the University of Tokyo and the RIKEN Center for Brain Science

Burton group wins image competition at Oxford BHF CRE Annual Symposium

This image of a blood clot composed of erythrocytes trapped by long fibrous chains of fibrin was judged the winner of the image competition at the BHF CRE 2022 Symposiium, held in December. In this image we can see false coloured erythrocytes (classic biconcave appearance around 5-10 µm in diameter) wrapped by fibrin network.

Understanding the brain at Didcot Girls School Science Club

A group of researchers and students led by Dr Tim Viney visited Didcot Girls School to run a ‘hands on’ event about the brain at the school’s Science Club.

Raised intracellular chloride levels underlie the effects of tiredness in cortex

The feeling of being tired is familiar to everyone. As we know from our own experience, an extended period of wakefulness results in a decline in our performance levels, and the desire to sleep becomes almost irresistible. When you then fall asleep, your sleep is deeper and more consolidated than usual. And yet after just one night of uninterrupted sleep, you can feel refreshed and “back to normal”!

Consequences of Tau pathology on hippocampal pyramidal neurons and network activity in ageing mice

Pathological hyperphosphorylated forms of the microtubule-associated binding protein Tau (pTau) are commonly found in people with neurodegenerative diseases, including Alzheimer’s disease, Corticobasal degeneration, and Progressive supranuclear palsy.